[WhiskeyTangoHotel] wrote in with his newest clock build — and he did warn us that it was minimalist and maybe less than useful. Indeed, it is nothing more than a super-cheap ESP32-C3 breakout board ...

A new ESC Clinical Consensus Statement is calling for greater awareness of the multidirectional relationship between mental health conditions and cardiovascular disease to improve patient health. The ...

Earlier, less-invasive treatment is at the core of the latest iteration of the joint European Society of Cardiology/European Association for Cardio-Thoracic Surgery (ESC/EACTS) valvular heart disease ...

MADRID, Spain—The European Society of Cardiology and the European Atherosclerosis Society (ESC/EAS) have updated their guidelines for the management of dyslipidemia, and while treatment goals have ...

At the European Society of Cardiology (ESC) Congress 2025, findings from a post-hoc analysis of the SURMOUNT-5 trial (NCT05822830) were presented, comparing tirzepatide to semaglutide for their impact ...

The European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) have just published the new international recommendations for managing dyslipidaemias. They were presented at ...

Top coverage from the 2024 European Society of Cardiology (ESC) Congress focused on screening, treatment, and equity in cardiovascular care. While previous trials have led to questions surrounding the ...

The European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) have released updated recommendations on the management of dyslipidaemia. The guidance presented at the ESC 2025 ...

Eyes in the pharma and medtech industries are directed to the European Society of Cardiology (ESC) Congress every year to examine the latest clinical trial data, observational study results, and ...

THE WOODLANDS, Texas, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced that a post-hoc analysis (“Efficacy of Sotagliflozin Among Older Adults: A Pooled ...

Add a beneficial impact on climate change to the long list of benefits being attributed to GLP-1 agonist medicines. An unusual study presented at the European Society of Cardiology (ESC) congress in ...